Lenacapavir just landed in Bulawayo as a game-changer for HIV prevention, but health officials are already flagging the gaps it leaves wide open for other STIs.
Bulawayo health officials back Lenacapavir rollout
Bulawayo health officials back Lenacapavir rollout
- City of Bulawayo Health Services director Dr Edwin Sibanda-Mzingwane praised the injectable PrEP.
- Lenacapavir shields against HIV but leaves other STIs completely uncovered.
- Drug-resistant gonorrhoea is already popping up globally, and that has Sibanda-Mzingwane spooked.
- Ditching condoms over HIV coverage could spark a whole new public health mess.
- Abstinence, faithfulness, and condom use remain solid weapons in the fight.
- Condoms still pull double duty against HIV, pregnancy, and STIs.
- Lenacapavir fits into a combo prevention strategy, not a standalone fix.
- Dropping condoms entirely would be a pretty reckless call, per officials.